A research team at Asan Medical Center has confirmed, through an extended follow-up study, that patients who received radiofrequency ablation (RFA) treatment for relapsed thyroid cancer remain healthy for long without recurrence or side effects.
The team, led by Professor Baek Jung-hwan, analyzed 29 patients who underwent RFA therapy for relapsed thyroid cancer from September 2008 to April 2012. The patients’ tumor size shrank by an average of 99.5 percent, and 42 of the 46 observed tumors disappeared entirely.

To read the complete journal, visit here AMC confirms efficacy of radiofrequency ablation therapy on thyroid cancer